Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984056 · ClinicalTrials.gov registry record · NA
Multidisciplinary Lifestyle Interventions for Neurological Disorders During the Silent Phase
A NA study of Neurological Disorder, sponsored by Vineet Punia MD.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05984056: Active NA study of Neurological Disorder, sponsored by Vineet Punia MD.
NCT05984056 is a NA study of Neurological Disorder that is active but no longer recruiting, run by Vineet Punia MD. The registered enrollment target is 200 participants, below the 528-participant average among 10 other Neurological Disorder trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05984056, a NA study of Neurological Disorder, is active but no longer recruiting, sponsored by Vineet Punia MD.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial aims to test the impact of multidisciplinary lifestyle interventions (MLI) in neurologically healthy but at-risk individuals. It aims to find out: * if giving four different kinds of lifestyle intervention and education slows down or reverses the expression of neurological disorder or their biomarkers. * new biomarkers that either help in the early detection of neurological disease or identify the impact of various lifestyle interventions combined. Participants will be randomized to the intervention or observation arm. Various biological samples and tests, along with survey questionnaires, will be performed at the time of entering the study, at 12 weeks after enrollment, and then at the end of the study at 12 months. * Intervention arm: Participants will receive weekly, instructor-led intervention sessions (virtual group sessions) for 12 weeks. After the 12-week mark, participants will be encouraged to practice what they learned for nine more months. * Observation arm: The intervention group will be compared to another group that did not get the intervention
Primary Outcome
At the time of study completion, a participant will be considered to show "Pathology progression" if they fulfill either of the two conditions: * Clinically diagnosed with any of the above four conditions * Show the following changes compared to the baseline: * Stroke: Asymptomatic cortical infarct or further increase in white matter disease MRI changes * Epilepsy: Increase in burden (per hour) of Spikes/Sharp Waves/Polyspikes or electrographic seizure on EEG * Movement Disorder: \>4 points inc
Conditions Studied
Interventions
- BEHAVIORAL Multidisciplinary lifestyle interventions
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-07-13 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT05984056 still lists
NCT05984056 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 528-participant average among 10 other Neurological Disorder trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Neurological Disorder appearing as the primary indexed condition, and to 1 intervention - of which Multidisciplinary lifestyle interventions is the first listed.
NCT05984056 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05984056 about?
NCT05984056 is a clinical study titled "Multidisciplinary Lifestyle Interventions for Neurological Disorders During the Silent Phase". This clinical trial aims to test the impact of multidisciplinary lifestyle interventions (MLI) in neurologically healthy but at-risk individuals. It aims to find out: * if giving four different kinds of lifestyle intervention and education slows down or reverses the expression of neurological disor...
What is the current status of trial NCT05984056?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-07-13. Estimated completion is 2026-06.
What conditions does trial NCT05984056 study?
This clinical trial studies the following conditions: Neurological Disorder.
What interventions are being tested in trial NCT05984056?
The interventions under investigation include: Multidisciplinary lifestyle interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05984056?
This trial is sponsored by Vineet Punia MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05984056 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurological Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05984056's enrollment target sits among peer trials
200 4th of 10 higher than 7 of 10 other Neurological Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurological Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
RECRUITING · NA
-
Transcutaneous Stimulation for Neurological Populations
RECRUITING · NA
-
Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery
RECRUITING · NA
-
Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
ACTIVE NOT RECRUITING · NA
-
Preventing Chronic Depression and PTSD in Stroke Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Family Caregivers
COMPLETED · NA
-
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI